Evidence map›Paper›PMID 34904053›Full record

ArticleF1000Research2021

Hematologic and coagulopathy parameter as a survival predictor among moderate to severe COVID-19 patients in non- ICU ward: a single-center study at the main referral hospital in Surabaya, East Java, Indonesia.

Siprianus Ugroseno Yudho Bintoro, Ni Made Intan Dwijayanti, Dana Pramudya, Putu Niken Amrita, Pradana Zaky Romadhon, Tri Pudy Asmarawati, Arief Bachtiar, Usman Hadi

Abstract read
In one paragraph

Article in F1000Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Siprianus Ugroseno Yudho BintoroHematology - Medical Oncology Division, Department of Internal Medicine, Airlangga University, Surabaya, East Java, 60132, Indonesia.ORCID 0000-0003-1360-5298
Ni Made Intan DwijayantiHematology - Medical Oncology Division, Department of Internal Medicine, Airlangga University, Surabaya, East Java, 60132, Indonesia.
Dana PramudyaDr. Soetomo General Teaching Hospital, Surabaya, East Java, 60286, Indonesia.
Putu Niken AmritaHematology - Medical Oncology Division, Department of Internal Medicine, Airlangga University, Surabaya, East Java, 60132, Indonesia.ORCID 0000-0003-4837-1786
Pradana Zaky RomadhonHematology - Medical Oncology Division, Department of Internal Medicine, Airlangga University, Surabaya, East Java, 60132, Indonesia.ORCID 0000-0001-9306-5425
Tri Pudy AsmarawatiDr. Soetomo General Teaching Hospital, Surabaya, East Java, 60286, Indonesia.ORCID 0000-0001-9869-5098
Arief BachtiarDr. Soetomo General Teaching Hospital, Surabaya, East Java, 60286, Indonesia.
Usman HadiDr. Soetomo General Teaching Hospital, Surabaya, East Java, 60286, Indonesia.ORCID 0000-0001-9348-7046

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19AdultAgedHospitalsHumansIndonesiaIntensive Care UnitsMiddle AgedReferral and ConsultationRetrospective StudiesSARS-CoV-2and well-beingcoagulopathycomorbidCOVID-19good healthhematology

Identifiers

PMID34904053
PMCPMC8596187.3

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.